A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 11,587 shares of DHR stock, worth $2.76 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,587
Previous 11,774 1.59%
Holding current value
$2.76 Million
Previous $2.94 Million 9.52%
% of portfolio
0.12%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$239.25 - $280.76 $44,739 - $52,502
-187 Reduced 1.59%
11,587 $3.22 Million
Q2 2024

Jul 11, 2024

SELL
$235.51 - $267.98 $59,113 - $67,262
-251 Reduced 2.09%
11,774 $2.94 Million
Q1 2024

May 10, 2024

SELL
$224.58 - $256.19 $23,805 - $27,156
-106 Reduced 0.87%
12,025 $3 Million
Q4 2023

Feb 06, 2024

BUY
$185.1 - $233.13 $1.96 Million - $2.47 Million
10,589 Added 686.71%
12,131 $2.81 Million
Q3 2023

Oct 19, 2023

SELL
$233.08 - $265.59 $48,480 - $55,242
-208 Reduced 11.89%
1,542 $382,000
Q2 2023

Aug 04, 2023

BUY
$224.99 - $256.14 $4,049 - $4,610
18 Added 1.04%
1,750 $420,000
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $109,326 - $126,312
456 Added 35.74%
1,732 $436,000
Q4 2022

Feb 03, 2023

BUY
$241.42 - $282.29 $24,142 - $28,229
100 Added 8.5%
1,276 $338,000
Q3 2022

Nov 01, 2022

BUY
$247.06 - $1507.4 $1,976 - $12,059
8 Added 0.68%
1,176 $304,000
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $24,896 - $31,464
-105 Reduced 8.25%
1,168 $296,000
Q1 2022

May 12, 2022

BUY
$257.27 - $315.76 $63,802 - $78,308
248 Added 24.2%
1,273 $373,000
Q4 2021

Jan 21, 2022

BUY
$292.08 - $329.01 $14,604 - $16,450
50 Added 5.13%
1,025 $337,000
Q3 2021

Nov 01, 2021

BUY
$272.21 - $332.43 $265,404 - $324,119
975 New
975 $297,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.